| Product Code: ETC12733039 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neoantigen Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neoantigen Market - Industry Life Cycle |
3.4 Israel Neoantigen Market - Porter's Five Forces |
3.5 Israel Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in the field of neoantigens |
4.2.2 Rising prevalence of cancer and increasing demand for personalized medicine |
4.2.3 Government initiatives and funding to support advancements in neoantigen therapy |
4.3 Market Restraints |
4.3.1 High costs associated with neoantigen therapies |
4.3.2 Stringent regulatory requirements for approval of neoantigen-based treatments |
4.3.3 Limited awareness and adoption of neoantigen therapies among healthcare providers and patients |
5 Israel Neoantigen Market Trends |
6 Israel Neoantigen Market, By Types |
6.1 Israel Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 Israel Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 Israel Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 Israel Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 Israel Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 Israel Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 Israel Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 Israel Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 Israel Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 Israel Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 Israel Neoantigen Market Import-Export Trade Statistics |
7.1 Israel Neoantigen Market Export to Major Countries |
7.2 Israel Neoantigen Market Imports from Major Countries |
8 Israel Neoantigen Market Key Performance Indicators |
8.1 Number of clinical trials involving neoantigen therapies in Israel |
8.2 Investment in Israeli biotech companies focusing on neoantigen research |
8.3 Number of collaborations between Israeli research institutions and pharmaceutical companies for neoantigen development. |
9 Israel Neoantigen Market - Opportunity Assessment |
9.1 Israel Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Neoantigen Market - Competitive Landscape |
10.1 Israel Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 Israel Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here